Skip to content

Medpace

NASDAQ: MEDP · USD

Medpace financials

6 charts

Revenue

USD millions

$707.331M
Medpace Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2016 Q3$107.799M; Change unavailable vs FY 2016 Q2
FY 2016 Q4$108.243M; +0.4% vs FY 2016 Q3
FY 2017 Q1$106.611M; −1.5% vs FY 2016 Q4
FY 2017 Q2$106.216M; −0.4% vs FY 2017 Q1
FY 2017 Q3$110.643M; +4.2% vs FY 2017 Q2
FY 2017 Q4$112.682M; +1.8% vs FY 2017 Q3
FY 2018 Q1$163.077M; +44.7% vs FY 2017 Q4
FY 2018 Q2$170.144M; +4.3% vs FY 2018 Q1
FY 2018 Q3$179.253M; +5.4% vs FY 2018 Q2
FY 2018 Q4$192.115M; +7.2% vs FY 2018 Q3
FY 2019 Q1$200.741M; +4.5% vs FY 2018 Q4
FY 2019 Q2$214.104M; +6.7% vs FY 2019 Q1
FY 2019 Q3$216.238M; +1.0% vs FY 2019 Q2
FY 2019 Q4$229.886M; +6.3% vs FY 2019 Q3
FY 2020 Q1$230.879M; +0.4% vs FY 2019 Q4
FY 2020 Q2$204.995M; −11.2% vs FY 2020 Q1
FY 2020 Q3$230.373M; +12.4% vs FY 2020 Q2
FY 2020 Q4$259.678M; +12.7% vs FY 2020 Q3
FY 2021 Q1$259.965M; +0.1% vs FY 2020 Q4
FY 2021 Q2$278.293M; +7.1% vs FY 2021 Q1
FY 2021 Q3$295.567M; +6.2% vs FY 2021 Q2
FY 2021 Q4$308.552M; +4.4% vs FY 2021 Q3
FY 2022 Q1$330.947M; +7.3% vs FY 2021 Q4
FY 2022 Q2$351.207M; +6.1% vs FY 2022 Q1
FY 2022 Q3$383.744M; +9.3% vs FY 2022 Q2
FY 2022 Q4$394.098M; +2.7% vs FY 2022 Q3
FY 2023 Q1$434.074M; +10.1% vs FY 2022 Q4
FY 2023 Q2$460.868M; +6.2% vs FY 2023 Q1
FY 2023 Q3$492.499M; +6.9% vs FY 2023 Q2
FY 2023 Q4$498.401M; +1.2% vs FY 2023 Q3
FY 2024 Q1$511.044M; +2.5% vs FY 2023 Q4
FY 2024 Q2$528.104M; +3.3% vs FY 2024 Q1
FY 2024 Q3$533.317M; +1.0% vs FY 2024 Q2
FY 2024 Q4$536.589M; +0.6% vs FY 2024 Q3
FY 2025 Q1$558.57M; +4.1% vs FY 2024 Q4
FY 2025 Q2$603.311M; +8.0% vs FY 2025 Q1
FY 2025 Q3$659.903M; +9.4% vs FY 2025 Q2
FY 2025 Q4$708.45M; +7.4% vs FY 2025 Q3
FY 2026 Q1$706.604M; −0.3% vs FY 2025 Q4
FY 2026 Q2$707.331M; +0.1% vs FY 2026 Q1
Sep 30, 2016 through Sep 25, 2026

Free cash flow

USD millions

$138.1M
Medpace Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2016 Q3$39.52M; Change unavailable vs FY 2016 Q2
FY 2016 Q4$23.877M; −39.6% vs FY 2016 Q3
FY 2017 Q1$-5.049M; −121.1% vs FY 2016 Q4
FY 2017 Q2$28.763M; +669.7% vs FY 2017 Q1
FY 2017 Q3$36.69M; +27.6% vs FY 2017 Q2
FY 2017 Q4$25.257M; −31.2% vs FY 2017 Q3
FY 2018 Q1$19.347M; −23.4% vs FY 2017 Q4
FY 2018 Q2$35.501M; +83.5% vs FY 2018 Q1
FY 2018 Q3$49.719M; +40.0% vs FY 2018 Q2
FY 2018 Q4$35.993M; −27.6% vs FY 2018 Q3
FY 2019 Q1$31.485M; −12.5% vs FY 2018 Q4
FY 2019 Q2$43.16M; +37.1% vs FY 2019 Q1
FY 2019 Q3$58.13M; +34.7% vs FY 2019 Q2
FY 2019 Q4$51.18M; −12.0% vs FY 2019 Q3
FY 2020 Q1$43.587M; −14.8% vs FY 2019 Q4
FY 2020 Q2$34.943M; −19.8% vs FY 2020 Q1
FY 2020 Q3$51.094M; +46.2% vs FY 2020 Q2
FY 2020 Q4$97.712M; +91.2% vs FY 2020 Q3
FY 2021 Q1$50.812M; −48.0% vs FY 2020 Q4
FY 2021 Q2$56.753M; +11.7% vs FY 2021 Q1
FY 2021 Q3$65.713M; +15.8% vs FY 2021 Q2
FY 2021 Q4$61.778M; −6.0% vs FY 2021 Q3
FY 2022 Q1$36.999M; −40.1% vs FY 2021 Q4
FY 2022 Q2$85.419M; +130.9% vs FY 2022 Q1
FY 2022 Q3$101.312M; +18.6% vs FY 2022 Q2
FY 2022 Q4$127.441M; +25.8% vs FY 2022 Q3
FY 2023 Q1$70.563M; −44.6% vs FY 2022 Q4
FY 2023 Q2$74.072M; +5.0% vs FY 2023 Q1
FY 2023 Q3$105.682M; +42.7% vs FY 2023 Q2
FY 2023 Q4$146.409M; +38.5% vs FY 2023 Q3
FY 2024 Q1$147.18M; +0.5% vs FY 2023 Q4
FY 2024 Q2$103.526M; −29.7% vs FY 2024 Q1
FY 2024 Q3$138.538M; +33.8% vs FY 2024 Q2
FY 2024 Q4$183.023M; +32.1% vs FY 2024 Q3
FY 2025 Q1$115.842M; −36.7% vs FY 2024 Q4
FY 2025 Q2$142.413M; +22.9% vs FY 2025 Q1
FY 2025 Q3$235.496M; +65.4% vs FY 2025 Q2
FY 2025 Q4$188.116M; −20.1% vs FY 2025 Q3
FY 2026 Q1$144.974M; −22.9% vs FY 2025 Q4
FY 2026 Q2$138.1M; −4.7% vs FY 2026 Q1

Net margin

%

17.16%
Medpace Net margin. Reported fiscal history.
Fiscal period%
FY 2016 Q34.67%
FY 2016 Q4-0.02%
FY 2017 Q17.92%
FY 2017 Q28.99%
FY 2017 Q38.89%
FY 2017 Q410.02%
FY 2018 Q18.92%
FY 2018 Q29.74%
FY 2018 Q310.77%
FY 2018 Q411.85%
FY 2019 Q19.56%
FY 2019 Q212.82%
FY 2019 Q311.09%
FY 2019 Q412.97%
FY 2020 Q112.54%
FY 2020 Q211.76%
FY 2020 Q318%
FY 2020 Q419.59%
FY 2021 Q116.66%
FY 2021 Q214.35%
FY 2021 Q316.43%
FY 2021 Q416.22%
FY 2022 Q118.53%
FY 2022 Q214.05%
FY 2022 Q317.21%
FY 2022 Q417.42%
FY 2023 Q116.79%
FY 2023 Q213.25%
FY 2023 Q314.32%
FY 2023 Q415.71%
FY 2024 Q120.07%
FY 2024 Q216.73%
FY 2024 Q318.08%
FY 2024 Q421.81%
FY 2025 Q120.52%
FY 2025 Q214.96%
FY 2025 Q316.84%
FY 2025 Q419.07%
FY 2026 Q117.53%
FY 2026 Q217.16%

P/E

× · TTM · Daily

35.95×
Medpace P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2017-03-3194.01×2016-12-31
2017-04-2899.87×2016-12-31
2017-05-3187.62×2016-12-31
2017-06-3091.34×2016-12-31
2017-07-3186.39×2016-12-31
2017-08-3157.96×2017-06-30
2017-09-2956.65×2017-06-30
2017-10-3166.54×2017-06-30
2017-11-3047.18×2017-09-30
2017-12-2951.36×2017-09-30
2018-01-3152.02×2017-09-30
2018-02-2831.01×2017-12-31
2018-03-2933.78×2017-12-31
2018-04-3035.79×2017-12-31
2018-05-3140.79×2017-12-31
2018-06-2941.61×2017-12-31
2018-07-3159.38×2017-12-31
2018-08-3157.85×2017-12-31
2018-09-2857.97×2017-12-31
2018-10-3150.41×2017-12-31
2018-11-3059.9×2017-12-31
2018-12-3151.22×2017-12-31
2019-01-3162.31×2017-12-31
2019-02-2828.09×2018-12-31
2019-03-2930.14×2018-12-31
2019-04-3028.71×2018-12-31
2019-05-3125.93×2019-03-31
2019-06-2831.42×2019-03-31
2019-07-3133.27×2019-06-30
2019-08-3034.18×2019-06-30
2019-09-3035.5×2019-06-30
2019-10-3129.89×2019-09-30
2019-11-2931.13×2019-09-30
2019-12-3134.13×2019-09-30
2020-01-3134.73×2019-09-30
2020-02-2833.92×2019-12-31
2020-03-3127.68×2019-12-31
2020-04-3027.61×2020-03-31
2020-05-2932.1×2020-03-31
2020-06-3032.17×2020-03-31
2020-07-3141.78×2020-06-30
2020-08-3145.43×2020-06-30
2020-09-3039.12×2020-06-30
2020-10-3033.77×2020-09-30
2020-11-3039.07×2020-09-30
2020-12-3142.37×2020-09-30
2021-01-2940.42×2020-09-30
2021-02-2642.24×2020-12-31
2021-03-3142.66×2020-12-31
2021-04-3040.24×2021-03-31
2021-05-2839.62×2021-03-31
2021-06-3041.88×2021-03-31
2021-07-3037.93×2021-06-30
2021-08-3139.31×2021-06-30
2021-09-3040.8×2021-06-30
2021-10-2946.69×2021-09-30
2021-11-3042.74×2021-09-30
2021-12-3144.85×2021-09-30
2022-01-3136.57×2021-09-30
2022-02-2831.52×2021-09-30
2022-03-3133.71×2021-09-30
2022-04-2924.35×2022-03-31
2022-05-3126.11×2022-03-31
2022-06-3027.28×2022-03-31
2022-07-2927.33×2022-06-30
2022-08-3123.8×2022-06-30
2022-09-3025.34×2022-06-30
2022-10-3131.6×2022-09-30
2022-11-3029.88×2022-09-30
2022-12-3030.24×2022-09-30
2023-01-3131.47×2022-09-30
2023-02-2825.62×2022-12-31
2023-03-3124.85×2022-12-31
2023-04-2825.06×2023-03-31
2023-05-3125.92×2023-03-31
2023-06-3030.07×2023-03-31
2023-07-3129.77×2023-06-30
2023-08-3131.79×2023-06-30
2023-09-2928.48×2023-06-30
2023-10-3128.23×2023-09-30
2023-11-3031.5×2023-09-30
2023-12-2935.66×2023-09-30
2024-01-3133.92×2023-09-30
2024-02-2944.79×2023-12-31
2024-03-2845.54×2023-12-31
2024-04-3039.79×2024-03-31
2024-05-3139.59×2024-03-31
2024-06-2842.2×2024-03-31
2024-07-3136.14×2024-06-30
2024-08-3033.56×2024-06-30
2024-09-3031.53×2024-06-30
2024-10-3127.58×2024-09-30
2024-11-2929.9×2024-09-30
2024-12-3129.16×2024-09-30
2025-01-3130.65×2024-09-30
2025-02-2825.8×2024-12-31
2025-03-3124.02×2024-12-31
2025-04-3023.1×2025-03-31
2025-05-3022.09×2025-03-31
2025-06-3023.51×2025-03-31
2025-07-3129.76×2025-06-30
2025-08-2933.13×2025-06-30
2025-09-3035.82×2025-06-30
2025-10-3138.93×2025-09-30
2025-11-2839.43×2025-09-30
2025-12-3137.38×2025-09-30
2026-01-3038.76×2025-09-30
2026-02-2729.02×2025-12-31
2026-03-3130.85×2025-12-31
2026-04-3026.34×2026-03-31
2026-05-2928.13×2026-03-31
2026-06-3033.31×2026-03-31
2026-07-3133.53×2026-06-30
2026-08-3134.51×2026-06-30
2026-09-2535.95×2026-06-30

ROIC

% · Annual / TTM

—
Medpace ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2016 Q3—
FY 2016 Q4—
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q35.45%
FY 2017 Q46.21%
FY 2018 Q17.14%
FY 2018 Q28.25%
FY 2018 Q39.92%
FY 2018 Q411.71%
FY 2019 Q1—
FY 2019 Q2—
FY 2019 Q3—
FY 2019 Q4—
FY 2020 Q1—
FY 2020 Q2—
FY 2020 Q3—
FY 2020 Q4—
FY 2021 Q1—
FY 2021 Q2—
FY 2021 Q3—
FY 2021 Q4—
FY 2022 Q1—
FY 2022 Q2—
FY 2022 Q3—
FY 2022 Q4—
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q4—
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q4—
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$318.675M
Medpace capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2016 Q31.01% · $2.15MUnavailable0% · $0MUnavailable98.99% · $210.018M100% · $212.168M
FY 2016 Q43.34% · $5.694MUnavailable0% · $0MUnavailable96.66% · $165.006M100% · $170.7M
FY 2017 Q158.57% · $4.374MUnavailableUnavailableUnavailable41.43% · $3.094M100% · $7.468M
FY 2017 Q25.28% · $1.645MUnavailable84.78% · $26.4MUnavailable9.93% · $3.093M100% · $31.138M
FY 2017 Q33.11% · $2.31MUnavailable92.72% · $68.855MUnavailable4.17% · $3.094M100% · $74.259M
FY 2017 Q45.08% · $3.395MUnavailable90.29% · $60.323MUnavailable4.63% · $3.094M100% · $66.812M
FY 2018 Q148.92% · $3.951MUnavailableUnavailableUnavailable51.08% · $4.125M100% · $8.076M
FY 2018 Q258.61% · $5.842MUnavailableUnavailableUnavailable41.39% · $4.125M100% · $9.967M
FY 2018 Q38.51% · $2.782MUnavailable0% · $0MUnavailable91.49% · $29.906M100% · $32.688M
FY 2018 Q49.2% · $3.449MUnavailable0% · $0MUnavailable90.8% · $34.032M100% · $37.481M
FY 2019 Q19.5% · $2.52MUnavailable0% · $0MUnavailable90.5% · $24M100% · $26.52M
FY 2019 Q25.79% · $3.47MUnavailable0% · $0MUnavailable94.21% · $56.438M100% · $59.908M
FY 2019 Q3100% · $6.162MUnavailable0% · $0MUnavailable0% · $0M100% · $6.162M
FY 2019 Q4100% · $5.76MUnavailable0% · $0MUnavailable0% · $0M100% · $5.76M
FY 2020 Q111.75% · $5.561MUnavailable88.25% · $41.776MUnavailable0% · $0M100% · $47.337M
FY 2020 Q250.74% · $9.324MUnavailable49.26% · $9.051MUnavailable0% · $0M100% · $18.375M
FY 2020 Q3100% · $8.669MUnavailable0% · $0MUnavailable0% · $0M100% · $8.669M
FY 2020 Q414.1% · $7.786MUnavailable85.9% · $47.447MUnavailable0% · $0M100% · $55.233M
FY 2021 Q1100% · $6.507MUnavailable0% · $0MUnavailableUnavailable100% · $6.507M
FY 2021 Q29.71% · $6.008MUnavailable90.29% · $55.877MUnavailableUnavailable100% · $61.885M
FY 2021 Q351.64% · $6.64MUnavailable48.36% · $6.219MUnavailableUnavailable100% · $12.859M
FY 2021 Q4100% · $9.116MUnavailable0% · $0MUnavailableUnavailable100% · $9.116M
FY 2022 Q12.13% · $9.257MUnavailable97.87% · $425.95MUnavailableUnavailable100% · $435.207M
FY 2022 Q22.9% · $11.2MUnavailable97.1% · $374.717MUnavailableUnavailable100% · $385.917M
FY 2022 Q3100% · $7.179MUnavailable0% · $0MUnavailableUnavailable100% · $7.179M
FY 2022 Q416.38% · $9.243MUnavailable83.62% · $47.182MUnavailableUnavailable100% · $56.425M
FY 2023 Q17.34% · $9.513MUnavailable92.66% · $120.146MUnavailableUnavailable100% · $129.659M
FY 2023 Q226.13% · $8.446MUnavailable73.87% · $23.874MUnavailableUnavailable100% · $32.32M
FY 2023 Q3100% · $8.703MUnavailable0% · $0MUnavailableUnavailable100% · $8.703M
FY 2023 Q4100% · $9.986MUnavailable0% · $0MUnavailableUnavailable100% · $9.986M
FY 2024 Q1100% · $5.497MUnavailable0% · $0MUnavailableUnavailable100% · $5.497M
FY 2024 Q2100% · $12.871MUnavailable0% · $0MUnavailableUnavailable100% · $12.871M
FY 2024 Q3100% · $10.537MUnavailable0% · $0MUnavailableUnavailable100% · $10.537M
FY 2024 Q44.31% · $7.643MUnavailable95.69% · $169.867MUnavailableUnavailable100% · $177.51M
FY 2025 Q12.62% · $9.994MUnavailable97.38% · $371.9MUnavailableUnavailable100% · $381.894M
FY 2025 Q21.12% · $6.113MUnavailable98.88% · $540.915MUnavailableUnavailable100% · $547.028M
FY 2025 Q370.08% · $10.713MUnavailable29.92% · $4.574MUnavailableUnavailable100% · $15.287M
FY 2025 Q4100% · $4.536MUnavailable0% · $0MUnavailableUnavailable100% · $4.536M
FY 2026 Q1100% · $6.814MUnavailable0% · $0MUnavailableUnavailable100% · $6.814M
FY 2026 Q27.5% · $23.911MUnavailable92.5% · $294.764MUnavailableUnavailable100% · $318.675M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Medpace.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources